Heart Lung Centre - Clinical Trials Unit

Heart Lung Centre - Clinical Trials Unit The Heart Lung Centre is a clinical trials unit based at the Fitzrovia Hospital in Central London.

Our major expertise lies in evaluating the mechanisms involved in respiratory diseases such as asthma and COPD (Chronic Obstructive Pulmonary Disease). In addition we assess the clinical potential of new therapeutic agents for both of these. We have a proven track record in performing clinically based pharmacological research in accordance with applicable regulatory requirements, UK clinical trial regulations and Good Clinical Practice (GCP).

Want to help with asthma research?We have a new 12-month phase 4 study which aims to assess the safety and efficacy of t...
12/06/2026

Want to help with asthma research?

We have a new 12-month phase 4 study which aims to assess the safety and efficacy of two inhalers, Trimbow and Foster in asthma subjects.

To be eligible to take part, you must:
👉 Have an Asthma diagnosis
👉 Be 18 years old or older
👉 Use a daily preventative inhaler for at least 3 months
👉 Taken oral steroids OR gone to hospital for a flare-up within the last year

You will be reimbursed for your participation!

Think you would be a good fit? Contact us!

If you are interested, please contact us by:
📞 calling us at 0207 034 3342
🖥 sending us an email at [email protected]
📱 or registering your interest on our website (link in bio)

05/06/2026

Are you interested in helping with Clinical Research?

If you have COPD and take regular inhalers, we might have a COPD clinical trial suitable for you!

We are looking for participants aged 40+ who must be smokers 🚬 or ex-smokers 🚭

You will be reimbursed for travel and inconvenience!

If you think this could be you or someone you know, register your interest at heartlungcentre.com/clinical-trials-request/ (link in our bio), DM us, or call us at 0207 034 3342.

Want to help with COPD research?Join our 11-week phase IV COPD study, which aims to assess the effects of an approved in...
29/05/2026

Want to help with COPD research?

Join our 11-week phase IV COPD study, which aims to assess the effects of an approved inhaler on heart and lung function in participants with COPD.

To be eligible to take part, you must:
👉 Have a COPD diagnosis
👉 Be 40 to 80 years old
👉 Use a daily preventative inhaler (non-blue inhaler) for at least 6 weeks
👉 Be a current or former smoker

You’ll be reimbursed for your travel up to £50 per visit and for your time up to £880.

If you are interested, please contact us by:
📞 calling us at 0207 034 3342
🖥 emailing us at [email protected]
📱 or registering your interest on our website (link in bio)

Want to help with COPD research?Join our 32-week phase II COPD study which aims to assess the safety and tolerability of...
22/05/2026

Want to help with COPD research?

Join our 32-week phase II COPD study which aims to assess the safety and tolerability of a newly developed anti-inflammatory medication for the treatment of COPD.

To be eligible to take part, you must:
👉 Have a COPD diagnosis for at least 1 year
👉 Be 40 to 75 years old
👉 Use a daily preventative inhaler (non-blue inhaler) for at least 3 months
👉 Be a former smoker for at least 6 months

You’ll be reimbursed for your travel up to £200 per visit and for your time up to £1,500.

If you are interested, please contact us by:
📞 calling us at 0207 034 3342
🖥 emailing us at [email protected]
📱 or registering your interest on our website (link in bio)

15/05/2026

And that’s a wrap on our myth-busting series! 🎉 We hope you enjoyed it and learned something new along the way. 💡

Got questions or ideas for content about clinical trials? Drop a comment below or send us a DM—we’d love to hear from you! 💬✨

08/05/2026

Myth No 10: People join clinical trials just for the money.

Fact: While financial compensation helps, people often join for other reasons, such as:

👉 Exploring other treatment options, if their current treatment isn’t working.
👉 Improving their understanding of their condition through free lung function and blood tests.
👉 Helping improve future treatments for others.

01/05/2026

Myth No 9: You must stop your usual treatment to join a clinical trial.

Fact: Many trials allow patients to stay on their current treatment alongside the study drug to improve outcomes.
If a trial requires stopping your treatment:

👉The study doctor ensures it’s safe for you to proceed.
👉This is to understand the standalone effect of the study drug and confirm that any results or side effects are not influenced by your usual medication.

24/04/2026

Myth No 8: Clinical trials are only for really sick people.

Fact: Clinical trials need participants at all stages of health!

👉 Many trials include healthy volunteers and people with non-fatal conditions who could benefit from improved treatments and care.
👉 Others seek newly diagnosed individuals or those with specific symptoms.
👉 Some trials are for patients who’ve exhausted other treatments.

17/04/2026

Myth No 7: Clinical trials are dangerous because they use untested medicines.

Fact: New treatments are first tested on animals to ensure basic safety before human trials begin.

Human trials progress through phases:
👉 Phase I: A small group of healthy volunteers tests safety and safe dosing.
👉 Phase II: A few hundred patients assess short-term effects and efficacy.
👉 Phase III: Hundreds to thousands patients trial the medicine to compare it to a placebo or existing treatment; often lasts years.
👉 Phase IV: Safety and effectiveness are monitored in practice (not required for all medicines).

Find out more at https://www.nhs.uk/conditions/clinical-trials/

10/04/2026

Myth No 6: If a study has a placebo, there’s a 50% chance I’ll get it.

Fact: The chance of receiving a placebo varies by study design. A placebo is an inactive substance that helps researchers see if the real treatment makes a difference.

👉 Some studies have more treatment groups than placebo groups, reducing the chance of getting a placebo.
👉 Others use a rotation system, so you experience both the placebo and treatment at different times.
👉 If the new medication is found to be effective, it may be offered to study participants in a follow-up study.

Address

Fitzrovia Hospital, 13-14 Fitzroy Square
London
W1T6AH

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Heart Lung Centre - Clinical Trials Unit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category